In vivo mapping of mutagenesis sensitivity of human enhancers.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40533554.
- Also identified by DOI 10.1038/s41586-025-09182-w and PMC identifier 13005948.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Distant-acting enhancers are central to human development<sup>1</sup>. However, our limited understanding of their functional sequence features prevents the interpretation of enhancer mutations in disease<sup>2</sup>. Here we determined the functional sensitivity to mutagenesis of human developmental enhancers in vivo. Focusing on seven enhancers that are active in the developing brain, heart, limb and face, we created over 1,700 transgenic mice for over 260 mutagenized enhancer alleles. Systematic mutation of 12-base-pair blocks collectively altered each sequence feature in each enhancer at least once. We show that 69% of all blocks are required for normal in vivo activity, with mutations more commonly resulting in loss (60%) than in gain (9%) of function. Using predictive modelling, we annotated critical nucleotides at the base-pair resolution. The vast majority of motifs predicted by these machine learning models (88%) coincided with changes in in vivo function, and the models showed considerable sensitivity, identifying 59% of all functional blocks. Taken together, our results reveal that human enhancers contain a high density of sequence features that are required for their normal in vivo function and provide a rich resource for further exploration of human enhancer logic.
Medical subject headings
- Enhancer Elements, Genetic
- Mutagenesis